<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03945422</url>
  </required_header>
  <id_info>
    <org_study_id>DO608522A</org_study_id>
    <nct_id>NCT03945422</nct_id>
  </id_info>
  <brief_title>The Use of RF in Premature Jowl and Neck Laxity Following Facialplasty</brief_title>
  <official_title>The Use of Radio Frequency in Premature Jowl and Neck Laxity Following Facialplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>InMode MD Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>InMode MD Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study is to evaluate the efficacy of treatment Radio Frequency in premature jowl and neck
      laxity following facialplasty
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 15, 2019</start_date>
  <completion_date type="Anticipated">April 3, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 3, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Subjects will receive the treatment and outcome will be followed</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in skin appearance</measure>
    <time_frame>3 months, 6 month, 9 months</time_frame>
    <description>Photos from all time points (baseline and follow-up visits) will be evaluated by the treating physician and 2 independent evaluators.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Investigator assessment of the skin appearance</measure>
    <time_frame>3 Month, 6 Months, 9 Months</time_frame>
    <description>Investigator assessment of the skin appearance improvement comparing pre and post treatment using 0 - 4 -points Likert scale: 4 = Significantly marked improvement; 3 = Marked improvement; 2 = Moderate improvement; 1 = Slight improvement ; 0 = No difference.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Optional: 3D Photographic analysis</measure>
    <time_frame>3 months, 6 month, 9 months</time_frame>
    <description>3D Photographic analysis will be conducted using QuantifiCare System</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate changes in skin appearance comparing photographs using Mechanical Turk (MTurk). The pictures will be sent through the system and evaluated by crowd workers.</measure>
    <time_frame>3 Months, 6 Months</time_frame>
    <description>The pictures will be sent through the system and evaluated by crowd workers.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Premature Jowl and Neck Laxity Following Facialplasty</condition>
  <arm_group>
    <arm_group_label>Treatment Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject will receive AccuTite/FaceTite and Morpheus8 treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AccuTite/FaceTite</intervention_name>
    <description>Radiofrequency-assisted lipolysis (RFAL) Morpheus8: Fractional RF</description>
    <arm_group_label>Treatment Arm</arm_group_label>
    <other_name>Morpheus8</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult females and males between the ages of 40-80 inclusive, having premature jowl
             and/or neck laxity one to fifteen years following facialplasty, seeking skin
             tightening treatments.

          -  Lack lipodystrophy in the jowl or neck area or at least not amenable to liposuction
             improvement (not a candidate for liposuction).

          -  Lack of previous Face Lift complications (no nerve injury or hematoma history).

          -  The patients should understand the information provided about the investigative nature
             of the treatment, possible benefits and side effects, and sign the Informed Consent
             Form, (including thepermission to use photography).

          -  The patients should be willing to comply with the study procedure and schedule,
             including the follow up visit, and will refrain from using any other aesthetic
             treatment methods for the last 6 months and during the entire study period.

        Exclusion Criteria:

          -  Pacemaker or internal defibrillator, or any other active electrical implant anywhere
             in the body.

          -  The Handpiece should be used at least 1cm away from cochlear implants in the ear.

          -  Superficial permanent implant in the treated area such as metal plates and screws,
             metal piercing, silicone implants or an injected chemical substance.

          -  Current or history of skin cancer (remission of 5 years), or current condition of any
             other type of cancer, or pre-malignant moles.

          -  Severe concurrent conditions, such as cardiac disorders, epilepsy, uncontrolled
             hypertension, and liver or kidney diseases.

          -  Pregnancy and nursing.

          -  History of bleeding coagulopathies or use of anticoagulants

          -  Impaired immune system due to immunosuppressive diseases such as AIDS and HIV or use
             of immunosuppressive medications.

          -  Poorly controlled endocrine disorders, such as diabetes or thyroid dysfunction and
             hormonalvirilization.

          -  Any active condition in the treatment area, such as sores, psoriasis, eczema, and
             rash.

          -  History of skin disorders, keloids, abnormal wound healing, as well as very dry and
             fragile skin.

          -  Use of Isotretinoin (AccutaneÂ®) within 6 months prior to treatment.

          -  Any surgery or treatment such as laser or chemicals in treated area within 3-6 months
             prior to treatment or before complete healing.

          -  Allergies, in particular to anesthesia.

          -  Mental disorders such as Body Dysmorphic Disorder (BDD).

          -  As per the practitioner's discretion, refrain from treating any condition that might
             make it unsafe for the patient.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chicago Center for Facial Plastics</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>May 7, 2019</study_first_submitted>
  <study_first_submitted_qc>May 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 10, 2019</study_first_posted>
  <last_update_submitted>September 23, 2019</last_update_submitted>
  <last_update_submitted_qc>September 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

